RxDoctor Payments Data

Melissa Dodd, APRN

Family · Murray, KYNPI 1629695770

Payments from drug & device makers

$1,309in general payments, 2019–2025

Across 65 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$189
  • Boston Scientific$163
  • Johnson & Johnson$155
  • Lilly USA, LLC$115
  • Novo Nordisk$107
  • Amgen$106
  • plus $473 from 16 others

What the payments were for

  • Food & beverage$1,21793%
  • Education$927%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,309 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$35,193
Medicare patients
135
Services billed
895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide13$15,476
SynthroidLevothyroxine Sodium21$854
Levothyroxine Sodium76$710
Tamsulosin Hcl24$688
Losartan Potassium53$475
Ezetimibe16$474
Amlodipine Besylate67$438
Montelukast Sodium23$425
Metoprolol Succinate33$408
Irbesartan15$398
Alprazolam48$367
Albuterol Sulfate HfaAlbuterol Sulfate16$365
Simvastatin29$300
Cyclobenzaprine Hcl19$298
Pregabalin15$290

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$115$15,47613 claims
AbbVieSynthroid$189$85421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Murray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →